These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37236305)

  • 1. Chronic liver disease-associated severe thrombocytopenia in Spain: Results from a retrospective study using machine learning and natural language processing.
    Calleja-Panero JL; Esteban Mur R; Jarque I; Romero-Gómez M; Group SR; García Labrador L; González Calvo J
    Gastroenterol Hepatol; 2024 Mar; 47(3):236-245. PubMed ID: 37236305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The burden associated with thrombocytopenia and platelet transfusions among patients with chronic liver disease.
    Elsaid MI; Rustgi VK; Loo N; Aggarwal K; Li-McLeod J; Niu X; Poordad F
    J Med Econ; 2020 Apr; 23(4):378-385. PubMed ID: 31777291
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluating medical resource utilization and costs associated with thrombocytopenia in chronic liver disease patients.
    Poordad F; Theodore D; Sullivan J; Grotzinger K
    J Med Econ; 2012; 15(1):112-24. PubMed ID: 21995622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human thrombopoietin treatment in patients with chronic liver disease-related thrombocytopenia undergoing invasive procedures: A retrospective study.
    Ding JN; Feng TT; Sun W; Cai XY; Zhang Y; Zhao WF
    World J Gastrointest Surg; 2022 Nov; 14(11):1260-1271. PubMed ID: 36504518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Characteristics and Prognostic Factors for Intensive Care Unit Admission of Patients With COVID-19: Retrospective Study Using Machine Learning and Natural Language Processing.
    Izquierdo JL; Ancochea J; ; Soriano JB
    J Med Internet Res; 2020 Oct; 22(10):e21801. PubMed ID: 33090964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of chronic liver disease-associated severe thrombocytopenia in Spain: a view from the experts.
    Calleja-Panero JL; Andrade RJ; Bañares R; Crespo J; Esteban R; Jarque I; Mingot-Castellano ME; Romero-Gómez M; Muñoz-Peñín R; Bentley R; Shepherd J; Gil Aguirre A
    Rev Esp Enferm Dig; 2020 Oct; 112(10):778-783. PubMed ID: 32954777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombopoietin Receptor Agonists in Patients with Chronic Liver Disease.
    Khemichian S; Terrault NA
    Semin Thromb Hemost; 2020 Sep; 46(6):682-692. PubMed ID: 32820479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Avatrombopag Before Procedures Reduces Need for Platelet Transfusion in Patients With Chronic Liver Disease and Thrombocytopenia.
    Terrault N; Chen YC; Izumi N; Kayali Z; Mitrut P; Tak WY; Allen LF; Hassanein T
    Gastroenterology; 2018 Sep; 155(3):705-718. PubMed ID: 29778606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using natural language processing to explore characteristics and management of patients with axial spondyloarthritis and psoriatic arthritis treated under real-world conditions in Spain: SpAINET study.
    Benavent D; Muñoz-Fernández S; De la Morena I; Fernández-Nebro A; Marín-Corral J; Castillo Rosa E; Taberna M; Sanabra C; Sastre C;
    Ther Adv Musculoskelet Dis; 2023; 15():1759720X231220818. PubMed ID: 38146537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Lusutrombopag on Post-invasive Procedural Bleeding in Thrombocytopenic Patients with Chronic Liver Disease.
    Yoshida M; Tateishi R; Hiroi S; Hongo Y; Fujiwara M; Kitanishi Y; Iwasaki K; Takeshima T; Igarashi A
    Adv Ther; 2022 Jan; 39(1):379-390. PubMed ID: 34748184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Platelet Count on Perioperative Bleeding in Patients With Cirrhosis Undergoing Surgical Treatments of Liver Cancer.
    Ronca V; Barabino M; Santambrogio R; Opocher E; Hodson J; Bertolini E; Birocchi S; Piccolo G; Battezzati P; Cattaneo M; Podda GM
    Hepatol Commun; 2022 Feb; 6(2):423-434. PubMed ID: 34716696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-life experience of lusutrombopag for cirrhotic patients with low platelet counts being prepared for invasive procedures.
    Takada H; Kurosaki M; Nakanishi H; Takahashi Y; Itakura J; Tsuchiya K; Yasui Y; Tamaki N; Takaura K; Komiyama Y; Higuchi M; Kubota Y; Wang W; Okada M; Shimizu T; Watakabe K; Enomoto N; Izumi N
    PLoS One; 2019; 14(2):e0211122. PubMed ID: 30768601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic Review with Meta-Analysis: Efficacy and Safety of Lusutrombopag for Severe Thrombocytopenia in Patients with Chronic Liver Disease Undergoing Invasive Procedures.
    Orme ME; Bentley R; Marcella S; Peck-Radosavljevic M; Perard R; Wedemeyer H; Yoshiji H; Agarwal K; Dusheiko G
    Adv Ther; 2022 Sep; 39(9):4169-4188. PubMed ID: 35836089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Avatrombopag: A Review in Thrombocytopenia.
    Markham A
    Drugs; 2021 Nov; 81(16):1905-1913. PubMed ID: 34709601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost Analysis of Platelet Transfusion in Italy for Patients with Chronic Liver Disease and Associated Thrombocytopenia Undergoing Elective Procedures.
    Mastrorilli G; Fiorentino F; Tucci C; Lombardi G; Aghemo A; Colombo GL
    Clinicoecon Outcomes Res; 2022; 14():205-220. PubMed ID: 35422645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lusutrombopag for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Invasive Procedures (L-PLUS 2).
    Peck-Radosavljevic M; Simon K; Iacobellis A; Hassanein T; Kayali Z; Tran A; Makara M; Ben Ari Z; Braun M; Mitrut P; Yang SS; Akdogan M; Pirisi M; Duggal A; Ochiai T; Motomiya T; Kano T; Nagata T; Afdhal N
    Hepatology; 2019 Oct; 70(4):1336-1348. PubMed ID: 30762895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a structured summary of a study protocol.
    Marietta M; Vandelli P; Mighali P; Vicini R; Coluccio V; D'Amico R;
    Trials; 2020 Jun; 21(1):574. PubMed ID: 32586394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Machine learning and natural language processing (NLP) approach to predict early progression to first-line treatment in real-world hormone receptor-positive (HR+)/HER2-negative advanced breast cancer patients.
    Ribelles N; Jerez JM; Rodriguez-Brazzarola P; Jimenez B; Diaz-Redondo T; Mesa H; Marquez A; Sanchez-Muñoz A; Pajares B; Carabantes F; Bermejo MJ; Villar E; Dominguez-Recio ME; Saez E; Galvez L; Godoy A; Franco L; Ruiz-Medina S; Lopez I; Alba E
    Eur J Cancer; 2021 Feb; 144():224-231. PubMed ID: 33373867
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.